Humana Q2 Adjusted EPS $7.61 Beats, GAAP Guidance Cut to $6.52 on Star Ratings Hit
HUM has more than doubled off its 52-week low of $163.11.
Summary
Humana reported Q2 adjusted EPS of $7.61, up from $6.27 a year ago and above the $9 full-year floor, beating estimates. The company reaffirmed its full-year adjusted EPS guidance of at least $9.00. However, GAAP EPS guidance was cut to at least $6.52 from $8.36 due to the Star Ratings headwind for Bonus Year 2026. The insurance segment benefit ratio was 91.2% in Q2, and the full-year outlook remains at 92.75% plus or minus 25 basis points. Individual Medicare Advantage membership growth is still expected to be about 25% in 2026. The conference call at 8:00 a.m. ET will provide further details on mitigation efforts and the Medicare Advantage business trajectory.
At the time of this announcement, HUM was trading at $372.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $46.7B. The 52-week trading range was $163.11 to $428.88. This news item was assessed with neutral market sentiment and an importance score of 8 out of 10. Source: BusinessWire.